Search

A new first in human phase 1 randomized, double-blind trial of Intralytix's ShigActive™, a Shigella phage preparation, shows it is safe and well tolerated when orally administered.

Welcome to the Podovirus podcast, episode 3! In this episode, I talk with Jesus Fernandez-Rodriguez from Eligo Bioscience, a Paris-based biotech company pioneering microbiome editing using modified bacteriophages. We talk about Eligo’s rece

It's Phage Picks time! This week we've got the sixth rendition of our new format, where we share the papers we keep bookmarked, and keep coming back to. Hi phage phans, I hope you’re enjoying the summer! There’s a lot packed into this mon

Why isn’t phage therapy a thing yet? What’s taking so long? I’m super excited to share our new podcast, Podovirus. This is a new experiment. I wanted a (better?) excuse to have in-depth conversations with some of my favorite phage people,

Guadalupe Valencia-Toxqui and Jolene Ramsey (Texas A&M University) published a new phage classification guide, orienting newcomers to four common ways phages are currently classified: infection cycle, morphology, taxonomy, and supergroup. B

Nicolas Kieffer (Universidad Complutense de Madrid) and colleagues published a new preprint on identification of phage defense systems encoded by mobile integrons, showing that integrons can encode phage defense systems, including Lamassu,

Max Wilkinson (Massachusetts Institute of Technology) and colleagues have described how phage-triggered reverse transcription assembles a toxic repetitive gene from a noncoding RNA, showing a new mode of genetic regulation in prokaryotes.

Rabia Fatima (McMaster University) and colleagues published a new paper on temperate phage-antibiotic synergy in P. aeruginosa, showing widespread synergy between temperate phages and antibiotics, but varying by phage, host, and antibiotic

Eleonora Turrini, Luca Ulfo (University of Bologna) and colleagues published a new paper on molecular engineering of an M13 phage nanovector for photodynamic treatment of colon cancer cells. They show effective colorectal cancer cell targe

Karolinska Institutet, Solna, Sweden is hiring a postdoc to investigate phage biology and enhance phage efficacy using genetic engineering techniques.

Congratulations to Simon Roux for winning the 2025 ASM Microbiome Data Prize for his outstanding contributions to microbiome research!

The Phage Hunters Training and Research Program (PHTRP) has launched a fundraiser to support their Phage Training Startup Fund. This initiative aims to equip young scientists in Africa and other developing countries with the skills needed

The ISVM (International Society for Viruses of Microbes is launching a logo design competition to create a new visual identity for the society, with submissions due by October 6th via the ISVM Board's email.

This week Aaryan Harshith, sophomore student at Stanford (and one of Jess' new labmates!) shares how and why he built a hand-curated database of phage TEM images. Check it out and add yours! Dear Phage community, Since this is my first pos

The Veterinary Biologicals Committee of the International Alliance for Biological Standardization will host a workshop on the quality, safety, and efficacy of phages for veterinary use on September 5, 2024, to discuss strategies for reducin

Humboldt University Berlin (Germany) is hiring a PhD position to investigate immune mechanisms of bacteria against phages using live-cell microscopy and bacterial genetics.

Why isn’t phage therapy a thing yet? What’s taking so long? I’m super excited to share our new podcast, Podovirus. This is a new experiment. I wanted a (better?) excuse to have in-depth conversations with some of my favorite phage people,

Only a few more days to vote for the International Society for Viruses of Microbes Executive Board candidates! (Ends Oct 21) ISVM members are invited to participate in the upcoming elections for the ISVM Executive Board to shape the future

Only a few more days to vote for the International Society for Viruses of Microbes Executive Board candidates! (Ends Oct 21) ISVM members are invited to participate in the upcoming elections for the ISVM Executive Board to shape the future

Nicholas Smith (University at Buffalo) and Dwayne Roach (San Diego State University) received a $3.6 million NIH grant to study pharmacokinetics and pharmacodynamics of mechanistically aware phage cocktails.